COCRYSTAL PHARMA INC's ticker is COCP and the CUSIP is 19188J300. A total of 34 filers reported holding COCRYSTAL PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $31,000 | -29.5% | 107,695 | 0.0% | 0.00% | – |
Q2 2022 | $44,000 | -25.4% | 107,695 | 0.0% | 0.00% | – |
Q1 2022 | $59,000 | -15.7% | 107,695 | -0.2% | 0.00% | – |
Q4 2021 | $70,000 | -38.1% | 107,921 | +0.1% | 0.00% | – |
Q3 2021 | $113,000 | -15.7% | 107,761 | -0.0% | 0.00% | – |
Q2 2021 | $134,000 | -10.1% | 107,795 | +0.0% | 0.00% | – |
Q1 2021 | $149,000 | +2.1% | 107,761 | 0.0% | 0.00% | – |
Q4 2020 | $146,000 | +46.0% | 107,761 | 0.0% | 0.00% | – |
Q3 2020 | $100,000 | -38.7% | 107,761 | +0.1% | 0.00% | – |
Q2 2020 | $163,000 | +114.5% | 107,695 | 0.0% | 0.00% | – |
Q1 2020 | $76,000 | +43.4% | 107,695 | 0.0% | 0.00% | – |
Q4 2019 | $53,000 | -76.4% | 107,695 | -1.8% | 0.00% | – |
Q3 2019 | $225,000 | -13.1% | 109,714 | -0.8% | 0.00% | – |
Q2 2019 | $259,000 | -13.4% | 110,644 | +0.9% | 0.00% | – |
Q1 2019 | $299,000 | -22.9% | 109,695 | +1.9% | 0.00% | – |
Q4 2018 | $388,000 | +44.2% | 107,695 | 0.0% | 0.00% | – |
Q3 2018 | $269,000 | +26800.0% | 107,695 | +64776.5% | 0.00% | – |
Q2 2018 | $1,000 | -75.0% | 166 | -75.4% | 0.00% | – |
Q1 2018 | $4,000 | – | 674 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 6,110,657 | $7,638,000 | 1.08% |
Altium Capital Management LP | 776,000 | $970,000 | 0.22% |
Alyeska Investment Group, L.P. | 2,750,100 | $3,438,000 | 0.04% |
Virtu Financial LLC | 116,625 | $146,000 | 0.01% |
Parallel Advisors, LLC | 184,708 | $231,000 | 0.01% |
Renaissance Technologies | 2,593,933 | $3,242,000 | 0.00% |
CIM, LLC | 11,000 | $12,000 | 0.00% |
Western Wealth Management, LLC | 19,115 | $24,000 | 0.00% |
Mariner, LLC | 200,055 | $250,000 | 0.00% |
BRIGHTON JONES LLC | 36,000 | $45,000 | 0.00% |